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Abstract Aims/hypothesis: Adaptation to energy restric-
tion is associated with changes in gene expression in
adipose tissue. However, it is unknown to what extent
these changes are dependent on the energy restriction as
such or on the macronutrient composition of the diet.
Methods: We determined the levels of transcripts for 38
genes that are expressed in adipose tissue and encode
transcription factors, enzymes, transporters and receptors
known to play critical roles in the regulation of adipo-
genesis, mitochondrial respiration, and lipid and carbohy-
drate metabolism. Two groups of 25 obese subjects
following 10-week hypocaloric diet programmes with
either 20–25 or 40–45% of total energy derived from fat
were investigated. Levels of mRNA were measured by
performing real-time RT-PCR on subcutaneous fat sam-
ples obtained from the subjects before and after the diets.
Results: The two groups of subjects lost 7 kg over the
duration of the diets. Ten genes were regulated by energy
restriction; however, none of the genes showed a sig-
nificantly different response to the diets. Levels of perox-
isome proliferator-activated receptor γ co-activator 1α
mRNA were increased, while the expression of the genes
encoding leptin, osteonectin, phosphodiesterase 3B, hor-
mone-sensitive lipase, receptor A for natriuretic peptide,
fatty acid translocase, lipoprotein lipase, uncoupling protein
2 and peroxisome proliferator-activated receptor γ was
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decreased. Clustering analysis revealed new potential
coregulation of genes. For example, the expression of the
genes encoding the adiponectin receptors may be regulated
by liver X receptor α. Conclusions/interpretation: In
accordance with the comparable loss of fat mass produced
by the two diets, this study shows that energy restriction
and/or weight loss rather than the ratio of fat: carbohydrate
in a low-energy diet is of importance in modifying the
expression of genes in the human adipose tissue.
Keywords Dietary fat and carbohydrate content . Low-
calorie diet . mRNA level . Nutrient composition .
Obesity . RT-PCR . White adipose tissue
Abbreviations NUGENOB: Nutrient–Gene Interactions
in Human Obesity—Implications for Dietary Guidelines .
PGC-1α: peroxisome proliferator-activated receptor γ co-
activator 1α . PPAR: peroxisome proliferator-activated
receptor
Introduction
Obesity is a major risk factor for type 2 diabetes and
weight reduction is an important component of the therapy
of the diabetic obese patient. Hypocaloric diets are widely
used to promote the negative energy balance necessary for
to reduce fat mass. There has been considerable interest in
dietary composition and weight loss [1]; however, it
remains to be determined which ratio of lipid : carbohy-
drate in a low-calorie diet most effectively facilitates
weight loss or improves metabolic profiles. A low-fat diet
is generally considered to be better than a high-fat diet
because the patient will benefit from reduced cardiovas-
cular risk as a result of weight loss and a restricted fat
intake. On the other hand, some subjects are more
compliant when placed on high-fat hypocaloric diets [2].
There have been few studies on the effect of altering the
fat and carbohydrate content of hypocaloric diets [3–7].
The small number of subjects included in these studies has
precluded the detection of clinically relevant differences in
weight loss and body composition. We recently performed
the Nutrient–Gene Interactions in Human Obesity—
Implications for Dietary Guidelines (NUGENOB) trial
on 771 obese subjects. This was a large randomised
intervention trial that was designed to study the effects of
low-fat, high-carbohydrate and high-fat, low-carbohydrate
hypocaloric diets (unpublished results). The results
indicated that the high-fat diet was as effective as the
low-fat diet in producing weight loss. Changes in fat mass,
fat-free mass, and waist and hip circumferences were not
significantly different between the two diet groups.
Little is known about the ways in which macronutrients
and energy restriction affect the regulation of adipose
tissue gene expression. Changes in the levels of a few
different mRNAs have been determined during 4-week
very-low-calorie diets [8–14] and 10-week low-calorie
diets [15]. To date, the determinants of gene expression in
adipose tissue during hypocaloric diets with different nu-
trient compositions have not been investigated in vivo.
Much progress has been made towards the elucidation of
the molecular mechanisms responsible for the effects of
nutrients on gene expression. Fatty acids have been found
to utilise several pathways [16, 17], and a glucose-
responsive transcription factor has been characterised [18,
19]. In addition, recent studies have investigated pathways
that mediate the effect of calorie restriction in mammals
[20, 21]. However, the extent to which changes in adipose
tissue gene expression are dependent on the calorie re-
striction as such or on the composition of the diet remains
unknown.
The aim of the present study was to investigate the
importance of nutrient composition and energy restriction
on the regulation of adipose tissue gene expression among
obese subjects enrolled in the NUGENOB programme.
The genes analysed were selected from different functional
categories of adipose tissue biology (Table 1). We studied
the expression of genes encoding transcription factors,
enzymes, transporters and receptors that are known to play
critical roles in the regulation of adipogenesis, mitochon-
drial respiration, and lipid and carbohydrate metabolism.
Transcripts encoding peptides secreted by adipose tissue
that act on other organs were also investigated.
Subjects and methods
Subjects and design Subjects were participants in the
European multicentre NUGENOB study (www.nugenob.
com), which was supported by the European Community.
Informed consent was obtained from all subjects. Clinical
investigations were approved by the ethical committees of
each participating centre and were performed according to
the Declaration of Helsinki. Subjects were randomly
assigned to one of two similarly energy-restricted diets: a
high-fat, low-carbohydrate diet or a low-fat, high-carbo-
hydrate diet. The present study included 50 women chosen
at random from the 771 obese patients who participated in
the initial study. Subjects were equally distributed between
the diets and the eight European clinical centres. The
patients were 21–49 years old and had a BMI >30 kg/m2
(mean BMI 36.2±0.7 kg/m2). During the dietary interven-
tion the subjects either visited or had telephone contact
with the dietician every week. The dietician then assessed
the compliance of the subjects and checked the content of
their diets from their food diaries. The subjects also
completed a 3-day weighed food record for two weekdays
and one weekend day before the start of the dietary
intervention and at the end of the 10-week diet. This was
done to assess the habitual diets of the subjects and to
estimate their compliance, respectively. Subjects com-
pleted 1-day weighed food records during the second, fifth
and seventh weeks of the intervention. The food records
were analysed using a food nutrient database. The two
diets decreased energy intake to the same extent (from
2271±627 to 1567±313 kcal/day on the high-fat diet, and
from 2301±554 to 1617±554 kcal/day on the low-fat diet).
In the low-fat diet, 24.4±3.2% of the total energy intake
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was derived from lipids (saturated, monounsaturated and
polyunsaturated fatty acids constituted 9.2±2.3, 9.8±2.3
and 5.4±1.4% of the total energy intake, respectively),
34.2±8.2% was from polysaccharides, and 24.6±6.9% was
from simple sugars. In the high-fat diet, 41.6±3.6% of the
total energy intake was supplied by lipids (saturated,
monounsaturated and polyunsaturated fatty acids consti-
tuted 15.3±3.6, 18.4±3.9 and 7.9±3.0% of the total energy
intake, respectively), 25.1±4.7% was from polysacchar-
ides, and 15.0±8.4% was from simple sugars. The subjects
were weighed when they visited the centres on every
second week of the study.
The total energy expenditure for each subject was
estimated as follows. The resting metabolic rate, measured
using a ventilated hood system, was expressed in kcal/day
and was multiplied by 1.3. From this value, 600 kcal were
subtracted to obtain the figure for a moderately hypocaloric
diet. In the low-fat diet, 20–25% of total energy was
provided by fat; the corresponding figure for the high-fat
diet was 40–45%. Both diets derived 15% of total energy
from protein and the remainder (60–65% and 40–45% for
the low-fat and high-fat diets, respectively) from carbohy-
drates. Fat mass and fat-free mass were assessed using
multifrequency bioimpedance (QuadScan 4000; Bodystat,
Douglas, Isle of Man, British Isles). Plasma leptin and
NEFA levels were determined using the human leptin RIA
kit (Linco research, St. Charles, MO, USA) and the NEFA-
C kit (Wako Chemicals, Neuss, Germany), respectively.
Quantitation of mRNA Before and after the dietary
intervention, biopsies of subcutaneous abdominal adipose
tissue (∼1 g) were performed under local anaesthesia
following an overnight fast. The samples were washed,
soaked in RNAlater preservative solution (Qiagen,
Courtaboeuf, France) and stored at −80°C until analysis.
Total RNA was extracted from subcutaneous adipose
tissue biopsies using the RNeasy total RNA Mini kit
(Qiagen). The integrity of total RNA was systematically
checked by electrophoresis through an agarose gel. After
DNase I treatment, 1 μg of total RNA was reverse tran-
scribed using random hexamers and poly(dT) as primers
and Superscript II reverse transcriptase (Invitrogen, Cergy
Pontoise, France). Quantitative real-time PCR was per-
formed using a GeneAmp 7000 Sequence Detection
System (Applied Biosystems, Foster City, CA, USA) or
a LightCycler (Roche Diagnostics, Meylan, France). For
each primer pair, a standard curve was obtained using
serial dilutions of human adipose tissue cDNA prior to
mRNA quantitation. To control for contamination by ge-
nomic DNA, quantitative PCR was performed on reverse
transcription reactions without reverse transcriptase. The
negative reverse transcription reactions had cycle thresh-
old (Ct) values >40, and the difference between the
negative and positive reactions was >10 Ct. All reactions
were performed in duplicate. When the difference between
the duplicates was above 0.5 Ct, quantitative PCR was
repeated. We used 18S rRNA as a control to normalise
gene expression using the Ribosomal RNA Control
TaqMan Assay kit (Applied Biosystems). We determined
the mRNA levels of 38 genes (Table 1). A list of primers
and PCR conditions are available upon request.
Statistical analysis The overall effect of the energy
restriction was tested using the paired Student’s t-test,
and gene expression data were logarithmically transformed
prior to analysis. General linear model univariate analysis
Fig. 1 Dendrogram of similarities in patterns of gene expression in
human adipose tissue during a hypocaloric diet. The relative
changes in levels of the different mRNAs between baseline and
week 10 of the diets were calculated and a hierarchical cluster
analysis was performed using Euclidean distances and Ward’s
method. The four main nodes are lettered on the graph. Please refer
to Table 1 for the full names of the proteins encoded by the genes
studied
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was used to study the differential effect of the diet, with
adjustment for baseline mRNA level (week 0) to increase
precision and statistical power [22]. The model included
adjustment for clinical centres. To control for changes in
other parameters that could hide the differential effect of
the diets (e.g., changes in BMI and fat mass), these
variables were entered independently into the model. A p
value less than or equal to 0.05 was considered statistically
significant. All analyses were performed using SPSS for
Windows, Version 11.5 (SPSS, Chicago, IL, USA).
Hierarchical cluster analysis was performed using Eu-
clidean distances as an estimate of similarity between two
genes and Ward’s method to join groups of genes [23, 24].
Cluster analysis is different to the Student’s t-test in that it
is used to identify similar variations as opposed to
significant changes. The dendrogram obtained using the
Ward algorithm (Fig. 1) was drawn from the percentage
changes in mRNA levels (mRNA level at week 10 minus
mRNA level at week 0 divided by mRNA level at week 0).
Results
Clinical data The anthropometric and clinical character-
istics of the subjects are shown in Table 2. The diets
reduced body weight by 6.75±0.45 kg and significantly
decreased plasma leptin by 29%. The changes observed in
weight and fat mass after 10 weeks were similar in the two
groups. Both the high-fat and low-fat groups achieved a
significant reduction in weight (6.7 and 6.8%, respec-
tively) and fat mass (13.3 and 14.9%, respectively).
Analysis of covariance using diet as a fixed factor did not
show a significant effect of the type of diet on the
anthropometric or metabolic parameters analysed except
for plasma NEFA (p=0.051). Circulating NEFA levels,
LDL cholesterol and HDL cholesterol decreased during
low-fat diet. The quantitative insulin sensitivity check
index (QUICKI), an indicator of insulin sensitivity, was
significantly increased in both groups.
Gene expression data We investigated changes in the
levels of expression of 38 genes with important roles in
adipocyte biology (Table 1). A general linear model
univariate analysis was performed to investigate the
differential effect of the two types of diets on gene
expression. The model was adjusted for baseline levels of
mRNA to control for inter-individual variations in ex-
pression. To control for changes in important baseline
determinants of gene expression that are modified during
hypocaloric diets, BMI, body fat, NEFA and leptin levels
were entered separately into the model. None of the genes
were identified as being differentially regulated by the
diets (p>0.1 for all), and the addition of the anthropometric
and plasma variables did not modify the results (data not
shown). In a second step we studied the overall effect of
the 10-week moderate energy restriction on gene expres-
sion in human adipose tissue. Table 3 shows that the
mRNA levels of ten genes were significantly changed.
Levels of osteonectin, phosphodiesterase 3B, receptor A Ta
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for natriuretic peptide (ANP-Ra), fatty acid translocase/
CD36, uncoupling protein 2, lipoprotein lipase, leptin,
hormone-sensitive lipase and peroxisome proliferator-
activated receptor γ2 (PPARγ2) mRNAs were lower
after 10 weeks of food restriction. Conversely, levels of the
transcript encoding PPARγ co-activator 1α (PGC-1α)
were increased. The changes in levels of mRNAs encoding
PGC-1α, leptin, lipoprotein lipase and osteonectin were
highly significant (p<0.001). These findings were not
modified by the inclusion of the baseline determinants of
gene expression in the analysis.
We used hierarchical clustering to ascertain which of the
genes exhibited similar patterns of expression. The clas-
sification algorithm was used to group the genes according
to their similarity in variations in mRNA levels. This pro-
vided cluster dendrograms that organised our observed data
into meaningful structures. Of the many methods available
for grouping data into clusters we chose the Ward method
which unifies groups in such a way that the intra-group
variability is minimised [23, 24]. This ensures that the
resulting groups are as homogenous as possible and that
the between-group differences are marked. Figure 1 shows
the hierarchical clustering of the 38 genes according to
changes in their levels of expression during the hypoca-
loric diets. Four master groups can be distinguished. Each
group contains genes that show similar patterns of ex-
pression. Some nodes contained transcription factors to-
gether with other genes suggesting that the transcription
factor could control the metabolic genes. One of the nodes
contained the eight genes that were downregulated during
calorie restriction.
Discussion
Although energy-restricted diets are often prescribed to
obese non-diabetic subjects and obese type 2 diabetic
subjects, little information is available on the changes that
occur in gene expression during low-calorie diets in
humans. Of the 38 genes that were selected based on their
importance in adipose tissue biology (Table 1), none were
differentially regulated according to the fat and carbohy-
drate content of the diet. Adjustment for baseline covariates
did not alter the outcome of this analysis. However, ten
genes were shown to be regulated by calorie restriction.
Therefore, the main finding of this extensive mRNA study
is the lack of effect of macronutrient composition and the
predominant impact of energy restriction and/or weight
loss on adipose tissue gene expression. The molecular
pathways that mediate the effects of fatty acids and glucose
on gene transcription have been partially characterised
[16–18]. Several of the genes investigated in this study are
directly regulated by fatty acids (adipocyte lipid binding
protein, uncoupling protein 2 and angiotensinogen) and
glucose (leptin, plasminogen activator inhibitor 1, fatty
acid synthase and hormone-sensitive lipase) in adipocytes
[25–31]. The greater reduction in plasma NEFA levels in
the low-fat group compared with the high-fat group had no
impact on gene expression. The changes in gene expressionTa
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may therefore be related to energy restriction and/or a
decrease in fat mass. These two parameters may regulate
mRNA levels via different mechanisms. In the short term,
fasting induces the expression of hormone-sensitive lipase
and uncoupling protein 2 mRNAs [32, 33], whereas
moderately hypocaloric diets of longer duration decrease
the levels of these two transcripts (Table 3). It may be
hypothesised that an acute negative energy balance
upregulates the expression of the gene encoding uncou-
pling protein 2 through an increase in plasma NEFA levels,
whereas a reduction in fat mass has a negative effect on the
expression of this gene [34]. Recent work has shown that
regulators of lifespan and mediators of the effect of calorie
restriction may be common to yeast, Caenorhabditis
elegans and mammals [35]. These regulators, including
sirtuin 1 (the mammalian orthologue of the yeast NAD-
dependent deacetylase SIR2) and the FOXO transcription
factors of the forkhead family which mediate some of the
transcriptional effects of insulin, may play an important
role in altering metabolism in response to calorie restric-
tion. It has recently been shown that sirtuin 1 is activated
during calorie restriction in adipose tissue and attenuates
adipogenesis through repression of PPARγ [20]. Our data
raise the possibility that the sirtuin 1 and/or FOXO path-
ways are involved in the regulation of adipose tissue gene
expression during hypocaloric diets in humans. However,
the direct involvement of these pathways remains to be
demonstrated.
The ten genes that were shown to be regulated by
energy restriction belong to different functional categories.
Several genes encoding secreted proteins were regulated.
Leptin levels have previously been shown to decrease
during a low-calorie diet [36]. We previously observed a
33% decrease in adipose tissue leptin mRNA levels during
a very-low-calorie diet which was accompanied by a 29%
decrease in circulating leptin levels [10]. Adiponectin is an
abundant adipose-tissue-secreted protein that plays im-
portant roles in glucose and lipid metabolism in both
skeletal muscle and liver. It has been suggested that
obesity and insulin resistance are associated with de-
creased adiponectin levels [37]. However, the increased
insulin sensitivity observed during calorie restriction is not
associated with changes in plasma levels of adiponectin or
the expression of the adiponectin gene in adipose tissue
[14]. Accordingly, levels of adiponectin mRNA were not
affected by the hypocaloric diets in this study, whereas
insulin sensitivity was improved. The mRNA levels of the
two recently characterised adiponectin receptors (adipo-
nectin receptors 1 and 2) were not regulated by either of
the two diets [38]. Hierarchical clustering suggests a role
for liver X receptor α in the regulation of the genes
encoding the two adiponectin receptors, as these three
genes showed highly similar patterns of expression during
the diets (Fig. 1). The expression of liver X receptor α is
induced during adipocyte differentiation, and this tran-
scription factor seems to regulate a subset of genes
involved in lipid metabolism [39]. It may therefore be of
interest to determine whether the adiponectin receptors are
direct targets of liver X receptor α, as has previously been
shown by a DNA-array-based global gene expression
profiling experiment using macrophages [40]. Osteonec-
tin, which is also known as secreted protein, acidic and
rich in cysteine (SPARC), is involved in extracellular
matrix remodelling, and osteonectin-deficient mice exhibit
increased fat deposition [41]. Furthermore, levels of
adipose tissue osteonectin mRNA have been observed to
be increased in ob/ob mice and in animals with diet- or
drug-induced obesity relative to those in lean mice [42].
Here, we show that weight loss is accompanied by a
downregulation of osteonectin gene expression.
The negative energy balance produced by a hypocaloric
diet is known to profoundly modify adipocyte metabolism,
particularly the lipolytic pathway [43]. Insulin counteracts
lipolysis, mainly through activation of phosphodiesterase
3B [44]. The slight decrease in phosphodiesterase 3B
mRNA levels observed in the present study could favour
an increase in fat cell cAMP levels and thus enhance
lipolysis. However, the decreased levels of hormone-
sensitive lipase and natriuretic peptide type A receptor
(which mediates cyclic GMP-dependent activation of
lipolysis in human adipocytes [45]) mRNAs indicate a
decreased lipolytic capacity. In addition, the expression of
hormone-sensitive lipase is reportedly decreased following
weight loss programmes [46, 47]. The downregulation of a
key enzyme responsible for triglyceride breakdown may
counterbalance the decrease in lipoprotein lipase mRNA
levels. Lipoprotein lipase controls the entry of fatty acids
derived from chylomicrons and VLDL into the fat cell. In
morbidly obese subjects, weight loss leads to decreases in
lipoprotein lipase mRNA levels and the activity of this
enzyme [48]. Fatty acid uptake from extracellular sources
is partially mediated by transmembrane transporters of
fatty acids. The key proteins involved are plasma mem-
brane fatty acid binding protein, fatty acid translocase/
CD36 and fatty acid transport protein 1. These transporters
may be regulated by nutritional challenges [49]. In the
present study, fatty acid translocase/CD36 mRNA levels
were significantly decreased, whereas the expression of
the other transporters and the intracellular adipocyte fatty
acid binding protein gene was not affected. As shown in
Fig. 1, PPARα is coexpressed with the genes encoding
the fatty acid transporters, plasma membrane fatty acid
binding protein and fatty acid transport protein 1. This
suggests that, in human adipose tissue, PPARα regulates
the transcription of the fatty acid transporter genes. In
support of the data, the fatty acid transport protein 1
promoter contains a functional PPARα response element
[50].
Several classes of transcription factors and nuclear
factors have been implicated in the control of adipogen-
esis. One of the four master nodes in the cluster analysis
(Fig. 1) contained the transcripts for the transcription
factors PPARγ, PPARβ and sterol regulatory element
binding protein 1c, all of which have been shown to play
critical roles in adipocyte differentiation and lipogenesis
[51, 52]. Two protein isoforms of PPARγ that differ in their
amino terminus region have been characterised: PPARγ1 is
expressed in several cell types, including adipocytes,
129
whereas PPARγ2 is almost exclusively expressed in
adipose tissue. The relative changes in the levels of
expression of PPARγ (PPARγ plus PPARγ2) and PPARγ2
were clustered together in a node containing the fatty acid
translocase/CD36 (Fig. 1), which is a well known target for
PPARγ in adipose tissue [53, 54]. The decreased PPARγ
mRNA levels observed in the present study are consistent
with previous reports [10, 55]. As fatty acid translocase/
CD36 and lipoprotein lipase are direct targets of PPARγ
[54, 56], their downregulation may be related to the
decreased expression of this transcription factor.
The expression of the gene encoding PGC-1α, a co-
activator of PPARγ, was upregulated. This was the only
gene induced by the diets studied. Together with several
classes of transcription factor, PGC-1α controls the
expression of genes involved in mitochondrial oxidative
phosphorylation [57], and it has been shown to promote
mitochondriogenesis in several tissues. The expression of
PGC-1α in human white adipocytes induces the expres-
sion of respiratory chain proteins, fatty acid oxidation
enzymes and brown adipocyte markers [58]. The upregu-
lation of this coactivator after a relatively short period of
calorie restriction may be viewed as an early adaptation of
the transcriptional activation of genes involved in mito-
chondrial energy metabolism that occurs after long-term
calorie restriction [59].
In summary, our data show the high-fat and low-fat low-
calorie diets produce similar reduction in anthropometric
parameters, including fat mass. In line with this, we
observed no differences in adipose tissue gene expression
between the two diets. Moderate energy restriction induced
an increase in the expression of PGC-1α, which encodes a
transcriptional coactivator that is linked to energy metab-
olism, and a decrease in the expression of genes involved in
lipid metabolism. The present study provides evidence that
energy restriction rather than the fat: carbohydrate ratio of a
low-calorie diet is of importance in the regulation of
transcription in the human adipocyte.
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